Clinical Trial Update: A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating REOLYSIN in combination with gemcitabine for metastatic pancreatic adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• REOLYSIN (pelareorep)

Snippet

Sponsor: Oncolytics Biotech | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED